Covered recipient · General Payments record
ADDISON ISZLER
General Payments · PY2024–2025
$210.03
- Reported across 10 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $190.59 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $49.46 | 2 |
| GlaxoSmithKline, LLC. | $38.96 | 2 |
| Novo Nordisk AS | $37.43 | 2 |
| Melinta Therapeutics, Inc. | $24.95 | 1 |
| Janssen Biotech, Inc. | $20.83 | 1 |
| DEXCOM, INC. | $18.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
Program year 2025 2024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.68 | 07/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202100505 | CMS |
| ABBVIE INC. | $26.78 | 09/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202100507 | CMS |
| Dexcom, Inc. | $18.96 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250466023 | CMS |
| GlaxoSmithKline, LLC. | $17.49 | 07/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191418395 | CMS |
| GlaxoSmithKline, LLC. | $21.47 | 10/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191158100 | CMS |
| Janssen Biotech, Inc. | $20.83 | 05/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175353013 | CMS |
| Melinta Therapeutics, LLC | $24.95 | 11/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1221034529 | CMS |
| Novo Nordisk Inc | $16.74 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1192978709 | CMS |
| Novo Nordisk Inc | $20.69 | 10/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1192976501 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.